These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37442960)

  • 1. Percutaneous transhepatic cholangial drainage or antibiotic therapy worsens response to immunotherapy in advanced cholangiocarcinoma.
    Huang Q; Wang F; Zhang X; Liu J; Dou X; Feng R; Zhu K; Jiang S; Zhang Y; Yue J
    BMC Cancer; 2023 Jul; 23(1):657. PubMed ID: 37442960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy of percutaneous transhepatic cholangioscopy-guided photodynamic therapy for postoperative recurrent extrahepatic cholangiocarcinoma.
    Chen Z; Jiang X; Xue P; Chen S; Li S; Li Z; Pan W; Zhang D
    Photodiagnosis Photodyn Ther; 2022 Dec; 40():103122. PubMed ID: 36115558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of endoscopic nasobiliary drainage versus percutaneous transhepatic cholangial drainage in the treatment of advanced hilar cholangiocarcinoma: a systematic review and meta-analysis.
    Zhou H; Liu C; Yu X; Su M; Yan J; Shi X
    BMC Gastroenterol; 2024 Sep; 24(1):302. PubMed ID: 39243020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postsurgical Management of Dilated Biliary Tract in Children: Ultrasound-Guided Percutaneous Transhepatic Cholangial Drainage and Subsequent Percutaneous Ultrasound Cholangiography.
    Shan QY; Jiang H; Chen SL; Chen HD; Guo Y; Xie XY; Zhou LY
    AJR Am J Roentgenol; 2020 Jun; 214(6):1377-1383. PubMed ID: 32160054
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety and efficacy of microwave ablation for periductal hepatocellular carcinoma with intraductal cooling of the central bile ducts through a percutaneous transhepatic cholangial drainage tube.
    Ge N; Huang J; Shi Z; Yu X; Shen S; Wu X; Zhou J; Hang Q; Yang Y
    J Interv Med; 2019 May; 2(2):84-90. PubMed ID: 34805878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and safety of preoperative percutaneous transhepatic cholangiodrainage with bile re-infusion in patients with hilar cholangiocarcinoma: a retrospective controlled study.
    Yu FX; Ji SQ; Su LF; Zhang SC; Zhang QY
    Am J Med Sci; 2013 Nov; 346(5):353-7. PubMed ID: 23276892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world outcomes of chemotherapy plus immune checkpoint inhibitors versus chemotherapy alone in advanced, unresectable, and recurrent intrahepatic cholangiocarcinoma.
    Madzikatire TB; Heng S; Gu H; Shan Y; Lin E; Banda J; Debora A; Madziva BA; Bowa MJ; Mudhuri MG; Bwalya C
    Front Immunol; 2024; 15():1390887. PubMed ID: 38846939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic outcomes of early and delayed endoscopic retrograde cholangiopancreatography and percutaneous transhepatic cholangial drainage in patients with obstructive severe acute biliary pancreatitis.
    Zhang XL; Sun JH; Wu Y; Xie M; Li CC; Lv D; Yu W; Cui PL
    J Clin Transl Res; 2023 Jun; 9(3):160-167. PubMed ID: 37457545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound-guided percutaneous transhepatic cholangiography and drainage in patients with hilar cholangiocarcinoma.
    Laméris JS; Hesselink EJ; Van Leeuwen PA; Nijs HG; Meerwaldt JH; Terpstra OT
    Semin Liver Dis; 1990 May; 10(2):121-5. PubMed ID: 1694044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous transhepatic cholangiography and drainage and endoscopic retrograde cholangiopancreatograph for hilar cholangiocarcinoma: which one is preferred?
    Zhu J; Feng H; Zhang D; Li R; Li J; Peng H; Tang W; Hu D; Wu W; Hu K; Cai W; Yin G
    Rev Esp Enferm Dig; 2020 Dec; 112(12):893-897. PubMed ID: 33118356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of different ways of drainage for obstructive jaundice caused by hilar cholangiocarcinoma.
    Xu C; Lv PH; Huang XE; Wang SX; Sun L; Wang FA
    Asian Pac J Cancer Prev; 2014; 15(14):5617-20. PubMed ID: 25081675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of different PD-1 inhibitor combination therapies for unresectable intrahepatic cholangiocarcinoma.
    Lei Z; Ma W; Si A; Zhang Y; Yang F; Yu Q; Tang H; Xiao Q; Zhou J; Wang K; Tang Y; Han T; Yin G; Chen J; Liu X; Zhao H; Yu D; Luo T; Wang Q; Yan M; Mao X; Li J; Wang K; Li J; Zeng Y; Ding D; Chen T; Wu X; Xia Y; Wang K; Guo W; Zhu G; Gao S; Hüser N; Lau WY; Song T; Cheng S; Shen F; Cheng Z
    Aliment Pharmacol Ther; 2023 Sep; 58(6):611-622. PubMed ID: 37349908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic arterial infusion chemotherapy plus lenvatinib with or without programmed cell death protein-1 inhibitors for advanced cholangiocarcinoma.
    Wei Z; Wang Y; Wu B; Liu Y; Wang Y; Ren Z; Yang X; Chen Q; Zhang Y
    Front Immunol; 2023; 14():1235724. PubMed ID: 37720223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A clinical observation of percutaneous balloon dilation and maintenance percutaneous transhepatic cholangial catheter drainage for treatment of 21 patients with benign biliary strictures and difficult endoscopy].
    Pan J; Shi HF; Li XG; Zhang XB; Liu W; Jin ZY; Hong T; Yang AM; Yang N
    Zhonghua Nei Ke Za Zhi; 2012 Jun; 51(6):433-6. PubMed ID: 22943751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous transhepatic cholangial drainage combined with percutaneous endoscopic jejunostomy for maintaining nutrition state in patients with advanced ampullary neoplasms.
    Sun Y; Li W; Sun D; Li S; Xu Q; Li Y; Lin Y; Qi Y; Yang T; Su K; Cen Y; Chen X; Xu P
    J Cancer Res Ther; 2018 Dec; 14(Supplement):S1158-S1162. PubMed ID: 30539863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of the Readiness for Hospital Discharge Scale for Patients with Bile Duct Carcinoma Catheterized After Percutaneous Transhepatic Cholangial Drainage: A Validity and Reliability Study.
    Zhao J; Ding W; Fan B; Chen C; Wang L
    Risk Manag Healthc Policy; 2024; 17():117-126. PubMed ID: 38229835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer.
    Derosa L; Hellmann MD; Spaziano M; Halpenny D; Fidelle M; Rizvi H; Long N; Plodkowski AJ; Arbour KC; Chaft JE; Rouche JA; Zitvogel L; Zalcman G; Albiges L; Escudier B; Routy B
    Ann Oncol; 2018 Jun; 29(6):1437-1444. PubMed ID: 29617710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Durvalumab in advanced cholangiocarcinoma: is someone knocking down the door?
    Ricci AD; D'Alessandro R; Rizzo A; Schirizzi A; Vallarelli S; Ostuni C; Troiani L; Lolli IR; Lotesoriere C; Giannelli G
    Immunotherapy; 2023 May; 15(7):477-486. PubMed ID: 36950960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of FGFR2 Alterations on Overall and Progression-Free Survival in Patients Receiving Systemic Therapy for Intrahepatic Cholangiocarcinoma.
    Abou-Alfa GK; Bibeau K; Schultz N; Yaqubie A; Millang B; Ren H; Féliz L
    Target Oncol; 2022 Sep; 17(5):517-527. PubMed ID: 36114955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of immune checkpoint inhibitors in unresectable or metastatic combined hepatocellular-cholangiocarcinoma.
    Jang YJ; Kim EJ; Kim HD; Kim KP; Ryu MH; Park SR; Choi WM; Lee D; Choi J; Shim JH; Kim KM; Lim YS; Lee HC; Ryoo BY; Yoo C
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7547-7555. PubMed ID: 36971796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.